Alector (ALEC) Share-based Compensation (2018 - 2026)
Alector (ALEC) reported Share-based Compensation of $2.9 million for Q1 2026, down 65.18% year-over-year from $8.4 million in Q1 2025, and down 39.95% quarter-over-quarter from $4.8 million in Q4 2025.
Alector (ALEC) Share-based Compensation (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Share-based Compensation data on file, last reported at $2.9 million in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $2.9 million, down 65.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.2 million (down 43.44% YoY), and the FY2025 annual result was $26.7 million, down 32.45% from the prior year.
- Share-based Compensation slipped to $2.9 million in Q1 2026 per ALEC's latest filing, from $4.8 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $12.5 million in Q2 2022 and troughed at $2.9 million in Q1 2026.
- A 5-year average of $9.3 million and a median of $10.2 million in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2026: Share-based Compensation soared 37.45% in 2022, then slumped 65.18% in 2026.
- A 5-year view of Share-based Compensation shows it stood at $11.0 million in 2022, then rose by 5.28% to $11.5 million in 2023, then retreated by 11.52% to $10.2 million in 2024, then sank by 52.58% to $4.8 million in 2025, then slumped by 39.95% to $2.9 million in 2026.
- Business Quant data shows ALEC's Share-based Compensation at $2.9 million in Q1 2026, $4.8 million in Q4 2025, and $6.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.91 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Dec 31, 2025 | 4.84 Mn |
| Dec 31, 2025 | 4.84 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Dec 31, 2024 | 10.21 Mn |
| Dec 31, 2024 | 10.21 Mn |
| Sep 30, 2024 | 9.04 Mn |
| Sep 30, 2024 | 9.04 Mn |
| Jun 30, 2024 | 9.91 Mn |
| Jun 30, 2024 | 9.91 Mn |
| Mar 31, 2024 | 10.31 Mn |
| Mar 31, 2024 | 10.31 Mn |
| Dec 31, 2023 | 11.54 Mn |
| Dec 31, 2023 | 11.54 Mn |